Publications found:
58,333
Sort by:
Acromegaly - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Acromegaly pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Acromegaly pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
80 pages
Acute Kidney Injury - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... . Report assists users in taking actionable steps Acute Kidney Injury pipeline report enables users to gain clear understanding into ... business in Acute Kidney Injury treatment pipeline. The report includes: The research work provides comprehensive overview of Acute Kidney Injury pipeline and treatment ...
April 2019
140 pages
Acute Renal Failure (ARF) - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments associated with each drug. Companies participating in Acute Renal Failure (ARF) pipeline Profiled in detail Key players actively ... business in Acute Renal Failure (ARF) treatment pipeline. The report includes: The research work provides comprehensive overview of Acute Renal Failure (ARF) pipeline ...
April 2019
144 pages
Alcoholic Hepatitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments associated with each drug. Companies participating in Alcoholic Hepatitis pipeline Profiled in detail Key ... Alcoholic Hepatitis treatment pipeline. The report includes: The research work provides comprehensive overview of Alcoholic Hepatitis pipeline and treatment landscape Complete list of drug ...
April 2019
65 pages
Amyloidosis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Amyloidosis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Amyloidosis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
100 pages
Anaphylaxis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Anaphylaxis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Anaphylaxis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
40 pages
Benign Prostatic Hyperplasia - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... Report assists users in taking actionable steps Benign Prostatic Hyperplasia pipeline report enables users to gain clear understanding ... in Benign Prostatic Hyperplasia treatment pipeline. The report includes: The research work provides comprehensive overview of Benign Prostatic Hyperplasia pipeline and ...
April 2019
89 pages
Birch Pollen Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... . Report assists users in taking actionable steps Birch Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Birch Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Birch Pollen Allergy pipeline and treatment ...
April 2019
50 pages
Cat Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Cat Allergy pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
35 pages
Cedar Pollen Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... . Report assists users in taking actionable steps Cedar Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Cedar Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Cedar Pollen Allergy pipeline and treatment ...
April 2019
40 pages
Celiac Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Celiac Disease pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
88 pages
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... with each drug. Companies participating in Cervical Intraepithelial Neoplasia (CIN) pipeline Profiled in detail Key players ... Cervical Intraepithelial Neoplasia (CIN) treatment pipeline. The report includes: The research work provides comprehensive overview of Cervical Intraepithelial Neoplasia (CIN) ...
April 2019
72 pages
Colitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Colitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Colitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
100 pages
Constipation - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... recent developments associated with each drug. Companies participating in Constipation pipeline Profiled in detail Key players actively participating in constipation pipeline are profiled along with their ...
April 2019
77 pages
Contrast Induced Nephropathy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... Report assists users in taking actionable steps Contrast Induced Nephropathy pipeline report enables users to gain clear understanding ... in Contrast Induced Nephropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Contrast Induced Nephropathy pipeline and ...
April 2019
35 pages
Cushing Syndrome - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Cushing Syndrome pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
58 pages
Diabetic Foot Ulcers - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... . Report assists users in taking actionable steps Diabetic Foot Ulcers pipeline report enables users to gain clear understanding into ... business in Diabetic Foot Ulcers treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Foot Ulcers pipeline and treatment ...
April 2019
145 pages
Diabetic Gastroparesis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... associated with each drug. Companies participating in Diabetic Gastroparesis pipeline Profiled in detail Key ... Diabetic Gastroparesis treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Gastroparesis pipeline and treatment landscape Complete list of drug ...
April 2019
55 pages
Diabetic Neuropathy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments associated with each drug. Companies participating in Diabetic Neuropathy pipeline Profiled in detail Key ... Diabetic Neuropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Neuropathy pipeline and treatment landscape Complete list of drug ...
April 2019
130 pages
Diabetic Peripheral Neuropathy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... Report assists users in taking actionable steps Diabetic Peripheral Neuropathy pipeline report enables users to gain clear understanding ... in Diabetic Peripheral Neuropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Peripheral Neuropathy pipeline and ...
April 2019
81 pages
Diarrhea - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Diarrhea pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Diarrhea pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
142 pages
End Stage Kidney Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... associated with each drug. Companies participating in End Stage Kidney Disease pipeline Profiled in detail Key players actively participating ... in End Stage Kidney Disease treatment pipeline. The report includes: The research work provides comprehensive overview of End Stage Kidney Disease pipeline ...
April 2019
42 pages
End Stage Renal Disease (ESRD) - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... associated with each drug. Companies participating in End Stage Renal Disease (ESRD) pipeline Profiled in detail Key players actively ... in End Stage Renal Disease (ESRD) treatment pipeline. The report includes: The research work provides comprehensive overview of End Stage Renal Disease (ESRD) pipeline ...
April 2019
40 pages
Endometriosis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Endometriosis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Endometriosis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
130 pages
Enterocolitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Enterocolitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Enterocolitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
43 pages
Eosinophilic Esophagitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... associated with each drug. Companies participating in Eosinophilic Esophagitis pipeline Profiled in detail Key ... Eosinophilic Esophagitis treatment pipeline. The report includes: The research work provides comprehensive overview of Eosinophilic Esophagitis pipeline and treatment landscape Complete list of drug ...
April 2019
61 pages
Erectile Dysfunction - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments associated with each drug. Companies participating in Erectile Dysfunction pipeline Profiled in detail Key ... Erectile Dysfunction treatment pipeline. The report includes: The research work provides comprehensive overview of Erectile Dysfunction pipeline and treatment landscape Complete list of drug ...
April 2019
98 pages
Exocrine Pancreatic Insufficiency - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... assists users in taking actionable steps Exocrine Pancreatic Insufficiency pipeline report enables users to gain clear understanding ... in Exocrine Pancreatic Insufficiency treatment pipeline. The report includes: The research work provides comprehensive overview of Exocrine Pancreatic Insufficiency pipeline and ...
April 2019
45 pages
Familial Amyloid Neuropathies - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... Report assists users in taking actionable steps Familial Amyloid Neuropathies pipeline report enables users to gain clear understanding ... in Familial Amyloid Neuropathies treatment pipeline. The report includes: The research work provides comprehensive overview of Familial Amyloid Neuropathies pipeline and ...
April 2019
50 pages
Female Contraception - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments associated with each drug. Companies participating in Female Contraception pipeline Profiled in detail Key ... Female Contraception treatment pipeline. The report includes: The research work provides comprehensive overview of Female Contraception pipeline and treatment landscape Complete list of drug ...
April 2019
70 pages
Female Hypoactive Sexual Desire Disorder - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... with each drug. Companies participating in Female Hypoactive Sexual Desire Disorder pipeline Profiled in detail Key players actively ... Female Hypoactive Sexual Desire Disorder treatment pipeline. The report includes: The research work provides comprehensive overview of Female Hypoactive Sexual Desire Disorder ...
April 2019
51 pages
Female Sexual Dysfunction - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... Report assists users in taking actionable steps Female Sexual Dysfunction pipeline report enables users to gain clear understanding ... business in Female Sexual Dysfunction treatment pipeline. The report includes: The research work provides comprehensive overview of Female Sexual Dysfunction pipeline and ...
April 2019
59 pages
Functional (NonUlcer) Dyspepsia - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... assists users in taking actionable steps Functional (NonUlcer) Dyspepsia pipeline report enables users to gain clear understanding ... in Functional (NonUlcer) Dyspepsia treatment pipeline. The report includes: The research work provides comprehensive overview of Functional (NonUlcer) Dyspepsia pipeline and ...
April 2019
40 pages
Gastric Ulcers - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Gastric Ulcers pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
45 pages
Gastritis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Gastritis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Gastritis pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
60 pages
Gastroenteritis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... action and recent developments associated with each drug. Companies participating in Gastroenteritis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Gastroenteritis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
47 pages
Gastroesophageal Reflux Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... assists users in taking actionable steps Gastroesophageal Reflux Disease pipeline report enables users to gain clear understanding ... in Gastroesophageal Reflux Disease treatment pipeline. The report includes: The research work provides comprehensive overview of Gastroesophageal Reflux Disease pipeline and ...
April 2019
76 pages
Glomerulonephritis - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... and recent developments associated with each drug. Companies participating in Glomerulonephritis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Glomerulonephritis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
150 pages
Grass Pollen Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... . Report assists users in taking actionable steps Grass Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Grass Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Grass Pollen Allergy pipeline and treatment ...
April 2019
50 pages
Graves Diseases - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Graves Diseases pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
39 pages
Hereditary Angioedema (HAE) - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... Report assists users in taking actionable steps Hereditary Angioedema (HAE) pipeline report enables users to gain clear understanding ... business in Hereditary Angioedema (HAE) treatment pipeline. The report includes: The research work provides comprehensive overview of Hereditary Angioedema (HAE) pipeline and ...
April 2019
68 pages
Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... each drug. Companies participating in Homozygous Familial Hypercholesterolemia (HoFH) pipeline Profiled in detail Key ... Homozygous Familial Hypercholesterolemia (HoFH) treatment pipeline. The report includes: The research work provides comprehensive overview of Homozygous Familial Hypercholesterolemia (HoFH ...
April 2019
58 pages
House Dust Mite Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,619.00
... developments associated with each drug. Companies participating in House Dust Mite Allergy pipeline Profiled in detail Key players actively participating ... in House Dust Mite Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of House Dust Mite Allergy pipeline ...
April 2019
54 pages
